Business News • PR NewsWire • CAR-T Cell Therapy Shows Promise In Treating Reoccurring Blood Cancers After Stem Cell Transplantation Without Causing Graft-vs.-Host Disease

CAR-T Cell Therapy Shows Promise In Treating Reoccurring Blood Cancers After Stem Cell Transplantation Without Causing Graft-vs.-Host Disease

CAR-T Cell Therapy Shows Promise In Treating Reoccurring Blood Cancers After Stem Cell Transplantation Without Causing Graft-vs.-Host Disease

ORLANDO, Fla., Dec. 6, 2015 /PRNewswire/ -- A new study co-authored by Regional Cancer Care Associates (RCCA) researchers from the John Theurer Cancer Center (JTCC) at Hackensack University Medical Center and presented here at the American Society of Hematology...

View More : http://www.prnewswire.com/news-releases/car-t-cell-therapy-shows-promise-in-treating-reoccurring-blood-cancers-after-ste...

Releted News by prnewswire

New Sickle Cell Disease Research Shows Improved Patient Outcomes And Reduced Disease Burden

Johnnie Walker® Scotch Whisky bietet während der Festtage eine sichere Fahrt nach Hause an, für insgesamt 450.000 km weltweit

GroupM Revises Down Global Ad Investment Growth To 4.5 Percent In 2016